Alliance Issues Analysis of President's FY 21 Request for FDA Funding

The Alliance for a Stronger FDA issued its analysis of the President’s FY 21 request for FDA funding on Monday this week; for details, please click here.In response to media inquiries, the Alliance has offered the following statement:

In relative terms, we are pleased that the Administration’s commitment to FDA remains strong, even while many other worthwhile agencies are proposed for cuts. In absolute terms, further increases are going to be needed for FDA because the mission and responsibilities of FDA are still growing and the science is becoming more complex.

We will have more detailed analysis in this week’s Friday Update. If you have any questions in the meantime, please contact Steven Grossman or Reed Diskey

Previous
Previous

Advocacy at a Glance

Next
Next

Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs